Hashimoto's Encephalopathy Versus Catatonia: A Diagnostic Dilemma

Overview

Journal J Family Med Prim Care

Specialty Public Health

Date 2023 Apr 24

PMID 37091027

Authors

Preeti Singh Dhoat

Amandeep Kaur

Niket Verma

Deepak Jain

Affiliations

Soon will be listed here.

Abstract

Hashimoto's encephalopathy is a rare life-threatening disease entity with clinical presentation like psychiatric as well as neurological diseases, thus making it a challenging clinical scenario for physicians leading to delay in diagnosis and management of the patient. The incidence overall is under-estimated because of low overall awareness about the disease. Here, we report a 44-year-old female who was being treated for psychiatric disorders because of clinical presentation like catatonia but ultimately was diagnosed with Hashimoto's encephalopathy and responded very well to steroids.

References

Chong J, Rowland L, Utiger R . Hashimoto encephalopathy: syndrome or myth?. Arch Neurol. 2003; 60(2):164-71. DOI: 10.1001/archneur.60.2.164. View

Daniels J . Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci. 2009; 21(4):371-80. DOI: 10.1176/jnp.2009.21.4.371. View

Chaudhuri A, Behan P . The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem. 2003; 10(19):1945-53. DOI: 10.2174/0929867033456945. View

Song Y, Seo D, Chang G . MR findings in Hashimoto encephalopathy. AJNR Am J Neuroradiol. 2004; 25(5):807-8. PMC: 7974481. View

Mocellin R, Walterfang M, Velakoulis D . Hashimoto's encephalopathy : epidemiology, pathogenesis and management. CNS Drugs. 2007; 21(10):799-811. DOI: 10.2165/00023210-200721100-00002. View

Ferracci F, Carnevale A . The neurological disorder associated with thyroid autoimmunity. J Neurol. 2006; 253(8):975-84. DOI: 10.1007/s00415-006-0170-7. View

Caselli R, Boeve B, Scheithauer B, ODuffy J, Hunder G . Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999; 53(7):1579-81. DOI: 10.1212/wnl.53.7.1579. View

Ferracci F, Bertiato G, Moretto G . Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004; 217(2):165-8. DOI: 10.1016/j.jns.2003.09.007. View

Northoff G, Wenke J, Pflug B . Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients. Psychol Med. 1996; 26(3):547-53. DOI: 10.1017/s0033291700035625. View

10.

Fink M, Taylor M . The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009; 66(11):1173-7. DOI: 10.1001/archgenpsychiatry.2009.141. View

11.

Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J . Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006; 63(2):197-202. DOI: 10.1001/archneur.63.2.197. View

12.

Sturzenegger M, Komor J, Baumgartner R, Hess C . Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996; 243(8):585-93. DOI: 10.1007/BF00900946. View